Package 42291-800-30

{"route": ["ORAL"], "spl_id": "4875aee4-c75a-ee36-e063-6394a90a9ce8", "openfda": {"upc": ["0342291800304"], "unii": ["OTT9J7900I"], "rxcui": ["349251"], "spl_set_id": ["7f0bc342-0a0a-1d28-e053-2991aa0a28b9"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (42291-800-30)", "package_ndc": "42291-800-30", "marketing_start_date": "20190110"}], "brand_name": "Tenofovir Disoproxil Fumarate", "product_id": "42291-800_4875aee4-c75a-ee36-e063-6394a90a9ce8", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "42291-800", "generic_name": "Tenofovir Disoproxil Fumarate", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tenofovir Disoproxil Fumarate", "active_ingredients": [{"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA090636", "marketing_category": "ANDA", "marketing_start_date": "20190110", "listing_expiration_date": "20271231"}